Clinical trial
Pharmacogenetics of Sodium-dependent Glucose Transporter-2 (SGLT2) Inhibitors
NCT02462421 is registered in ClinicalTrials.gov with University of Maryland, Baltimore as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pharmacogenetics of Sodium-dependent Glucose Transporter-2 (SGLT2) Inhibitors
- Lead sponsor
- University of Maryland, Baltimore
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- June 1, 2015
- Completion date
- December 31, 2021
- Enrollment
- 30 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.